Hepatitis B and C infections in HIV-1 patients on combination antiretroviral therapy (cART) in Ghana: implications for immunologic recovery, clinical response to treatment, and hepatotoxicity
Open Access
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, KenyaBMC Research Notes, 2013
- HBV and HCV seroprevalence and their correlation with CD4 cells and liver enzymes among HIV positive individuals at University of Gondar Teaching Hospital, Northwest EthiopiaVirology Journal, 2013
- Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, EthiopiaBMC Immunology, 2013
- Sero-prevalence of hepatitis B virus and hepatitis C virus among HIV patients in a suburban University Teaching Hospital in South-East NigeriaPan African Medical Journal, 2013
- Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus InfectionPLOS ONE, 2012
- Prevalence and impact of hepatitis B and C virus co‐infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in GhanaJournal of Medical Virology, 2011
- HIV, hepatitis B, and hepatitis C in ZambiaJournal of Global Infectious Diseases, 2011
- Detection of Highly Prevalent Hepatitis B Virus Coinfection among HIV-Seropositive Persons in GhanaJournal of Clinical Microbiology, 2010
- Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History StudyAIDS Research and Therapy, 2010
- Hepatitis B and long-term HIV outcomes in coinfected HAART recipientsAIDS, 2009